Gene therapy for arthritis
- 1 May 2003
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (10) , 902-911
- https://doi.org/10.1038/sj.gt.3302040
Abstract
Rheumatoid arthritis is an autoimmune disease with intra-articular inflammation and synovial hyperplasia that results in progressive degradation of cartilage and bone, in severe cases it causes systemic complications. Recently, biological agents that suppress the activities of proinflammatory cytokines have shown efficacy as antiarthritic drugs, but require frequent administration. Thus, gene transfer approaches are being developed as an alternative approach for targeted, more efficient and sustained delivery of inhibitors of inflammatory cytokines as well as other therapeutic agents. Indeed, the efficacy of gene transfer for the treatment of arthritis has been demonstrated in mouse, rat, rabbit, and horse models of disease whereas the feasibility of the approach has been demonstrated in Phase I clinical trials. In this review, the current status of both preclinical and clinical arthritis gene therapy is presented. In addition, the advantages and disadvantages of different types of vectors, target cells and therapeutic genes being developed for the treatment of arthritis are summarized. Finally, the future directions of the rapidly developed field of arthritis gene therapy are outlinedKeywords
This publication has 97 references indexed in Scilit:
- C3‐Tat/HIV–regulated intraarticular human interleukin‐1 receptor antagonist gene therapy results in efficient inhibition of collagen‐induced arthritis superior to cytomegalovirus‐regulated expression of the same transgeneArthritis & Rheumatism, 2002
- Interleukin-13 Gene Therapy Reduces Inflammation, Vascularization, and Bony Destruction in Rat Adjuvant-Induced ArthritisHuman Gene Therapy, 2002
- Advances in Understanding the Genetic Basis of Rheumatoid Arthritis and OsteoarthritisAmerican Journal of PharmacoGenomics, 2002
- Inhibitor of nuclear factor ?B kinase ? is a key regulator of synovial inflammationArthritis & Rheumatism, 2001
- Successful Gene Therapy via Intraarticular Injection of Adenovirus Vector Containing CTLA4IgG in a Murine Model of Type II Collagen-Induced ArthritisHuman Gene Therapy, 2001
- A novel doxycycline inducible autoregulatory plasmid which displays ‘on’/‘off’ regulation suited to gene therapy applicationsGene Therapy, 2000
- Anti-Cytokine Therapy for Rheumatoid ArthritisAnnual Review of Medicine, 2000
- Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclastsJournal of Clinical Investigation, 1999
- THE MULTIFACETED REGULATION OF INTERLEUKIN-15 EXPRESSION AND THE ROLE OF THIS CYTOKINE IN NK CELL DIFFERENTIATION AND HOST RESPONSE TO INTRACELLULAR PATHOGENSAnnual Review of Immunology, 1999
- Gene Therapy for Rheumatoid ArthritisDrugs & Aging, 1998